Related Experiment Video
Updated: Apr 11, 2026

09:04
Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
Published on: April 22, 2017
9.6K
Cellular stage specific functional analysis of REX1: In human embryonic stem cells
Yong Jun Kim1,2, Gabsang Lee1,2,3
1Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Proteomics
|June 11, 2015
Summary
Proteomics revealed the true functions of the REX1 pluripotency marker in human embryonic stem cells (hESCs). This study highlights proteomics
Area of Science:
- Stem cell biology
- Proteomics
- Molecular mechanisms
Background:
- Transcription and translation dynamics necessitate advanced methods for understanding protein function.
- Previous transcriptome analysis offered limited insight into pluripotency mechanisms.
- REX1 is a key pluripotency marker in human embryonic stem cells (hESCs).
Purpose of the Study:
- To identify the tissue-specific functions of the REX1 protein using proteomics.
- To unravel the regulatory network controlled by REX1 in maintaining pluripotency.
- To demonstrate the significance of integrating proteomics with stem cell research.
Main Methods:
- Proteome analysis of REX1 in hESCs.
- Identification of REX1's regulatory network.
- Comparison with prior transcriptome data.
Main Results:
- Proteomics identified REX1 functions more relevant to cellular mechanisms than transcriptome analysis.
- The study elucidated REX1's regulatory network crucial for orchestrating pluripotency.
- Biological importance and conceptual significance of REX1 in stem cell biology were demonstrated.
Conclusions:
- Proteomics provides a more accurate view of protein functions in specific cellular contexts.
- REX1 plays a critical role in maintaining pluripotency through a defined regulatory network.
- Integrating proteomics with stem cell biology offers deeper insights into cellular mechanisms.
Related Concept Videos
Embryonic Stem Cells
33.5K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.5K
Embryonic Stem Cells
6.0K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
6.0K
Maintenance of the ES Cell State
2.8K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K

